Screener
CytomX Therapeutics CTMX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: CytomX Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211868
FAQ
- What is CytomX Therapeutics's net change in cash?
- CytomX Therapeutics (CTMX) reported net change in cash of $16.16M in Q1 2026.
- How has CytomX Therapeutics's net change in cash changed year-over-year?
- CytomX Therapeutics's net change in cash increased by 69.2% year-over-year, from $9.55M to $16.16M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about CytomX Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude